Tang, PA
Aimin Tang, Lansdale, PA US
Patent application number | Description | Published |
---|---|---|
20110008369 | PD-1 BINDING PROTEINS - The present invention features PD-1 binding proteins, a subset of which inhibits binding of PD-L1 to the PD-1 receptor. These binding proteins can be employed to modulate the immune system through the manipulation of the PD-1 signaling pathway, enhancing host immunity to treat infections and cancer. | 01-13-2011 |
Aimin Tang, Landsdale, PA US
Patent application number | Description | Published |
---|---|---|
20110136896 | VARIANT HCMV PP65, IE1, AND IE2 POLYNUCLEOTIDES AND USES THEREOF - The present invention relates to compositions and methods to elicit or enhance cell-mediated immunity against HCMV infection by providing polynucleotides encoding variant HCMV pp65, IE1, and IE2 proteins, and fusion proteins thereof. The present invention also provides recombinant vectors including, but not limited to, adenovirus and plasmid vectors comprising said polynucleotides and host cells comprising said recombinant vectors. Also provided herein are purified forms of the variant HCMV pp65, IE1, and IE2 proteins described herein, and fusion proteins. The variant HCMV proteins, and fusion proteins thereof, are useful as vaccines for the protection from and/or treatment of HCMV infection. Said vaccines are useful as a monotherapy or a part of a therapeutic regime, said regime comprising administration of a second vaccine such as a polynucleotide, cell-based, protein or peptide-based vaccine. | 06-09-2011 |
Cha Min Tang, Wayne, PA US
Patent application number | Description | Published |
---|---|---|
20090209867 | METHOD FOR RAPID SCREENING OF MAD COW DISEASE AND OTHER TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES - Methods for diagnosing altered neuropathology in an animal are disclosed, wherein said methods comprise imaging brain, spinal cord, or other neural tissue of the animal, analyzing the appearance of the tissue, and determining whether the appearance of the tissue is altered relative to corresponding unaltered tissue. Also disclosed are methods for diagnosing spongiform encephalopathies in an animal, wherein said methods comprise imaging brain, spinal cord, or other neural tissues of the animal, analyzing the appearance of vacuoles in the tissue, and determining whether the appearance of the vacuoles in the tissue is altered relative to corresponding spongiform encephalopathy-free tissue. Also disclosed are automated methods for diagnosing altered neuropathy and spongiform encephalopathies. | 08-20-2009 |
20150126976 | Ultraviolet Sterilizing Drainage Catheter - A device disclosed herein includes a tubular member which is flexible and configured to receive ultraviolet (UV) light from a UV illumination coupler. The tubular member contains a lumen defining a longitudinal interior space within the tubular member, a tubular body bounded by an inner wall defining an outer boundary of the lumen and an outer wall defining an outer surface of the tubular member, at least one optical fiber disposed outside of the interior space not parallel to an axis of the lumen and adapted to receive the UV light from the UV illumination coupler, and a protective component adapted to prevent substantively all of the UV light emitted from the optical fiber from exiting the outer wall. Methods for producing and using such devices are also disclosed herein. | 05-07-2015 |
Cha-Min Tang, Radnor, PA US
Patent application number | Description | Published |
---|---|---|
20090264981 | METHOD OF USING OPTICAL COHERENCE TOMOGRAPHY (OCT) IN SURGERY - Methods comprising the use of optical coherence tomography to examine a harvested conduit for its suitability for grafting, to examine a candidate conduit prior to harvesting for coronary artery bypass graftings to assess the quality of an anastomosis, to assess the quality of the suturing of a small vessel or duct with a suture coated with a contrast agent, and to detect coronary artery disease in a harvested donor heart prior to transplantation. | 10-22-2009 |
20140043618 | Coherence Gated Doppler Motion Sensor and Medical Applications - A motion sensor applicable to medical procedures includes a source of light with a wavelength bandwidth and an optical detector. A first optical coupler terminates in a first probe tip and couples the light into the first probe tip. A second optical coupler terminates in a second probe tip and directs onto the detector scattered light returning through the second probe tip. A presentation device outputs a signal that indicates motion in a target volume of a sample in a vicinity of the probe tips based on a Doppler shift of the scattered light. The volume depends on coherence distance determined by the bandwidth. In variations, the first and second tips are the same tip, a multimode fiber is included, the bandwidth is between 0.1% and 5% of a center wavelength, or the presentation device is a speaker, or some combination. | 02-13-2014 |
Chaucer C. Tang, Kennett Square, PA US
Patent application number | Description | Published |
---|---|---|
20110165390 | DECORATIVE LAMINATED SAFETY GLASS - The present invention is a decorative laminated article comprising an image bearing thermoplastic interlayer wherein the image has been printed on the interlayer using an ink jet printing process, wherein the pigment comprises at least one pigment selected from the group consisting of: PY 120; PY 155; PY 128; PY 180; PY 95; PY 93; PV19/PR 202; PR 122; PB 15:4; PB 15:3; and PBI 7. The interlayer material of the present invention can be, for example, PVB, PET, or polyurethane. | 07-07-2011 |
20110245078 | SEED COATING COMPOSITION - The invention pertains to a seed coating composition comprising a certain latex binder and/or graft polymer dispersant. The seed coating composition imparts good color to treated seeds, has excellent durability, and is non-sticky after application to allow for smooth flow of coated seed in planting equipment. | 10-06-2011 |
Haizhong Tang, Radnor, PA US
Patent application number | Description | Published |
---|---|---|
20110098498 | Processes For Preparing A Polymeric Compound - The present invention provides methods for preparing a polymeric compound of Formula I: | 04-28-2011 |
20120115877 | Facially Amphiphilic Compounds, Compositions, And Uses Thereof In Treating Cancer - The present invention discloses compositions of facially amphiphilic compounds and their use in methods for treating or reducing cancers in animals, such as humans. | 05-10-2012 |
20130252964 | Compounds And Methods For Treating Candidiasis And Aspergillus Infections - The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for killing or inhibiting the growth of a | 09-26-2013 |
20130274502 | Processes For Preparing A Polymeric Compound - The present invention provides methods for preparing a polymeric compound of Formula I: | 10-17-2013 |
20150197485 | Processes For Preparing A Polymeric Compound - The present invention provides methods for preparing a polymeric compound of Formula I: | 07-16-2015 |
Hong Tang, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20130202752 | CHOCOLATE PRODUCTION METHOD AND APPARATUS - The present invention relates to a method and an apparatus for producing a chocolate product. The method includes delivering liquid chocolate having a viscosity through a pipe along a delivery path to a production station for producing the chocolate product. The liquid chocolate includes solid particles suspended within the liquid chocolate. The method changes the viscosity of the liquid chocolate by applying an electric field to the liquid chocolate in a direction along the delivery path of a strength and duration determined to aggregate the suspended solid particles into streamlined shapes extending along the direction of the delivery path. | 08-08-2013 |
20150237880 | CHOCOLATE PRODUCTION METHOD AND APPARATUS - The present invention relates to a method and an apparatus for producing a chocolate product. The method includes delivering liquid chocolate having a viscosity through a pipe along a delivery path to a production station for producing the chocolate product. The liquid chocolate includes solid particles suspended within the liquid chocolate. The method changes the viscosity of the liquid chocolate by applying an electric field to the liquid chocolate in a direction along the delivery path of a strength and duration determined to aggregate the suspended solid particles into streamlined shapes extending along the direction of the delivery path. | 08-27-2015 |
Hsin Yao Tang, Media, PA US
Patent application number | Description | Published |
---|---|---|
20140100130 | Methods and Compositions for the Diagnosis of Ovarian Cancer - A diagnostic reagent or device comprises at least one ligand capable of specifically complexing with, binding to, or quantitatively detecting or identifying the biomarker chloride intracellular channel protein 4 (CLIC4) or an isoform, pro-form, modified molecular form including posttranslational modification, or unique peptide fragment or nucleic acid fragment thereof. An alternative diagnostic reagent or device comprises ligand or ligands capable of specifically complexing with, binding to, or quantitatively detecting or identifying multiple tropomyosin biomarkers. Optionally, such reagent or device includes a signaling molecule and/or a substrate on which the ligand is immobilized. Other reagents and methods of diagnosing ovarian cancer include use of CLIC4 ligands and/or multiple tropomyosin ligands with an additional ovarian cancer biomarker. For example, CLIC4 combined with one or more of CLIC1 and/or one or multiple members of the tropomyosin family, e.g., TPM1, TPM2, TPM3 or TPM4, and further optionally including CTSD-30 kDa and/or PRDX-6, among other ovarian cancer biomarkers can form a characteristic diagnostic pattern or profile of expression that is diagnostic of the disease. Still other embodiments are described. | 04-10-2014 |
20140121127 | Methods and Compositions for Diagnosis of Ovarian Cancer - Methods and compositions are provided for diagnosing ovarian cancer in a mammalian subject, preferably in a serum or plasma sample of a human subject. The methods and compositions enable the detection or measurement in the sample or from a protein level profile generated from the sample, the protein level of one or more specified biomarkers. Comparing the protein level(s) of the biomarker(s) in the subject's sample or from protein abundance profile of multiple biomarkers, with the level of the same biomarker(s) or profile in a reference standard, permits the determination of a diagnosis of ovarian cancer, or the identification of a risk of developing ovarian cancer, or enables the monitoring of the status of progression or remission of ovarian cancer in the subject followed during a therapeutic protocol. | 05-01-2014 |
20140274794 | Methods and Compositions for Diagnosis of Ovarian Cancer - Methods and compositions are provided for diagnosing ovarian cancer in a mammalian subject, preferably in a serum or plasma sample of a human subject. The methods and compositions enable the detection or measurement in the sample or from a protein level profile generated from the sample, the protein level of one or more specified biomarkers. Comparing the protein level(s) of the biomarker(s) in the subject's sample or from protein abundance profile of multiple biomarkers, with the level of the same biomarker(s) or profile in a reference standard, permits the determination of a diagnosis of ovarian cancer, or the identification of a risk of developing ovarian cancer, or enables the monitoring of the status of progression or remission of ovarian cancer in the subject followed during a therapeutic protocol. | 09-18-2014 |
Jia Tang, Phoenixville, PA US
Patent application number | Description | Published |
---|---|---|
20140170327 | WATERBORNE TWO COMPONENT POLYURETHANE COATING COMPOSITIONS COMPRISING ALICYCLIC RIGID POLYOLS - The present invention provides two-component polyurethane compositions that are substantially free of VOCs and comprising, as one component, polyisocyanate compositions and, as a second component, a polyol which is chosen from a cycloaliphatic diol or polyol having a molecular weight of from 100 to 500 and containing one or more 4 to 7 member aliphatic ring and an oligomeric diol or polyol comprising the condensation reaction product of from 30 wt. % to 78 wt. %, based on the total weight of reactants used to make the oligomer, and an acrylic or vinyl emulsion polymer. | 06-19-2014 |
20150307742 | NITROFUNCTIONAL POLYURETHANE DISPERSIONS FOR BINDER COMPOSITIONS - Provided is a binder composition and its use in aqueous based paints and coatings and other applications. The binder composition comprises: a polyurethane dispersion containing water and a polyurethane polymer, wherein the polyurethane polymer is prepared by reacting a nitroalcohol compound, a polyol compound, a polyisocyanate compound, and optionally chain extenders, wherein the nitroalcohol compound is of formula I, wherein R, R | 10-29-2015 |
Jia Tang, Ambler, PA US
Patent application number | Description | Published |
---|---|---|
20120130002 | POLYURETHANE COATING COMPOSITIONS COMPRISING ISOCYANURATE COMPOSITIONS FROM BIS(ISOCYANATOMETHYL) CYCLOHEXANE AND TERTIARY AMINE CATALYSTS - The present invention provides high solids, two-component polyurethane compositions comprising, as one component, polyisocyanate compositions having one or more isocyanurate made from bis(isocyanatomethyl)-cyclohexane, as a second component, one or more high solids polyol, and in either component, one or more tertiary amine catalyst. Optionally, the compositions further comprise one or more zinc amine catalyst. The compositions provide coatings, which exhibit an excellent balance of pot life and dry to touch or tack free time, as well as early rain resistance and hardness, while enabling a lower volatile organic content (VOC) of the compositions for comparable performance. | 05-24-2012 |
Jiangbo Tang, Drexel Hill, PA US
Patent application number | Description | Published |
---|---|---|
20110245309 | N-METHYLPURINE DNA GLYCOSYLASE AND POLYMERASE BETA AS BIOMARKERS FOR ALKYLATOR CHEMOTHERAPY POTENTIATION - Described herein is the finding that polymerase β (Polβ) and N-methylpurine DNA glycosylase (MPG) can be used as biomarkers to evaluate the sensitivity of a subject to combination therapy that includes treatment with either temozolomide (TMZ) and methoxyamine, or TMZ and a poly(ADP-ribose) polymerase (PARP) inhibitor. Thus, provided herein is a method of determining if a subject will be sensitive to TMZ and methoxyamine, or TMZ and a PARP inhibitor by measuring expression of Polβ and MPG in a sample from the subject and comparing expression of Polβ and MPG in the sample to a control. A decrease in expression of Polβ and an increase in expression of MPG relative to the control indicates the subject is sensitive to TMZ and methoxyamine, or sensitive to TMZ and the PARP inhibitor. | 10-06-2011 |
20130316349 | N-METHYLPURINE DNA GLYCOSYLASE AND POLYMERASE BETA AS BIOMARKERS FOR ALKYLATOR CHEMOTHERAPY POTENTIATION - Described herein is the finding that polymerase β (Polβ) and N-methylpurine DNA glycosylase (MPG) can be used as biomarkers to evaluate the sensitivity of a subject to combination therapy that includes treatment with either temozolomide (TMZ) and methoxyamine, or TMZ and a poly(ADP-ribose) polymerase (PARP) inhibitor. Thus, provided herein is a method of determining if a subject will be sensitive to TMZ and methoxyamine, or TMZ and a PARP inhibitor by measuring expression of Polβ and MPG in a sample from the subject and comparing expression of Polβ and MPG in the sample to a control. A decrease in expression of Polβ and an increase in expression of MPG relative to the control indicates the subject is sensitive to TMZ and methoxyamine, or sensitive to TMZ and the PARP inhibitor. | 11-28-2013 |
Minh Tang, Yardley, PA US
Patent application number | Description | Published |
---|---|---|
20090262037 | SPACE SEGMENT PAYLOAD ARCHITECTURE FOR MOBILE SATELLITE SERVICES (MSS) SYSTEMS - A antenna system for generating and distributing power among a plurality of non-focused beams is provided The system comprises a reflector having a focal plane and a non-parabolic curvature configured to form the defocused beams. The curvature is configured to create a symmetrical quadratic phase-front in an aperture plane of the reflector. The system further comprises a plurality of feed antennas disposed in the focal plane of the reflector and configured to illuminate the reflector. Each feed antenna is configured to contribute power toward each of the defocused beams. The system further comprises a plurality of fixed-amplitude amplifiers, at least one of which corresponds to each feed antenna. | 10-22-2009 |
Pei Tang, Wexford, PA US
Patent application number | Description | Published |
---|---|---|
20150307582 | ENGINEERED RECEPTORS AND THEIR USE - Engineered chloride channel receptors, nucleic acids encoding these receptors, expression vectors including these nucleic acids are disclosed herein. Nanoparticles and pharmaceutical compositions including these engineered chloride channel receptors, nucleic acids, and expression vectors are disclosed. The use of these compositions and nanoparticles, such as for the treatment of pain, cystic fibrosis and asthma, is also disclosed. | 10-29-2015 |
Phan L. Tang, West Chester, PA US
Patent application number | Description | Published |
---|---|---|
20080207861 | Curable base-resistant fluoroelastomers - Compositions of fluoroelastomers containing copolymerized units of tetrafluoroethylene, propylene, a first cure site selected from the group consisting of i) trifluoroethylene, ii) 3,3,3-trifluoropropene-1, iii) 1,2,3,3,3-pentafluoropropylene, iv) 1,1,3,3,3-pentafluoropropylene, and v) 2,3,3,3-tetrafluoropropene, and a second cure site selected from the group consisting of i) copolymerized units of a brominated cure site monomer, ii) copolymerized units of an iodinated cure site monomer, iii) copolymerized units of a chlorinated cure site monomer, iv) brominated endgroups, v) iodinated endgroups and vi) a combination of any of i)-v) are readily curable with polyhydroxy curing systems. The resulting cured articles have a combination of excellent resistance to alkaline fluids, superior tensile properties and compression set resistance, and excellent adhesion to metal substrates. Optionally, the fluoroelastomers may be dual cured by both a polyhydroxy system and an organic peroxide system. | 08-28-2008 |
Phan Linh Tang, West Chester, PA US
Patent application number | Description | Published |
---|---|---|
20090124754 | PROCESS FOR PRODUCING FLUOROPOLYMERS - An emulsion polymerization process for the production of fluoropolymers is disclosed wherein a combination of at least two fluorosurfactants is employed as dispersants. At least one fluorosurfactant is a perfluoroalkyl or perfluoroalkoxy sulfinate. At least one other fluorosurfactant is a perfluoropolyether having at least one endgroup selected from the group consisting of carboxylic acid, a slat thereof, sulfonic acid and a salt thereof. | 05-14-2009 |
20090124755 | PROCESS FOR PRODUCING FLUOROPOLYMERS - An emulsion polymerization process for the production of fluoropolymers that contain polymerized units of tetrafluoroethylene is disclosed wherein a perfluoroaliphatic sulfinate is employed as dispersant. | 05-14-2009 |
20090186997 | PROCESS FOR PRODUCING FLUOROELASTOMERS - An emulsion polymerization process for the production of fluoroelastomers is disclosed wherein at least one fluorosurfactant is employed as dispersant, said fluorosurfactant being a fluoroalkylphosphoric acid ester of the formula X—Rf—(CH | 07-23-2009 |
20100120980 | FLUOROALKYL ETHER SULFONATE SURFACTANTS - A compound of Formula (1) | 05-13-2010 |
20100121025 | FLUOROSULFONATES - A process comprising polymerizing in an aqueous medium at least one fluorinated olefin monomer other than vinylidene fluoride in the presence of a compound of formula (1): | 05-13-2010 |
20110245135 | FLUOROSULFONATES - A process comprising polymerizing in an aqueous medium at least one fluorinated olefin monomer other than vinylidene fluoride in the presence of a compound of formula (1): | 10-06-2011 |
20110257423 | PROCESS FOR PRODUCING FLUOROELASTOMERS - An emulsion polymerization process for the production of fluoroelastomers is disclosed wherein at least one fluorosurfactant is employed as dispersant, said fluorosurfactant being a fluoroalkylphosphoric acid ester of the formula X—Rf—(CH | 10-20-2011 |
20150073111 | FLUOROELASTOMERS HAVING SECONDARY CYANO GROUP CURE SITES - This invention pertains to fluoroelastomers comprising copolymerized units of vinylidene fluoride, at least one other fluoroolefin and a cure site monomer having a secondary cyano group, as well as cured fluoroelastomer compositions made therefrom. It has been surprisingly discovered that fluoroelastomers that contain a cure site monomer having a secondary cyano group contain much less gel than do similar fluoroelastomers that employ a cure site monomer having a primary cyano group. Furthermore cured (i.e. crosslinked) fluoroelastomer compositions that contain a fluoroelastomer having secondary cyano groups have a better (i.e. lower) compression set than do similar cured fluoroelastomer compositions that contain a fluoroelastomer having primary cyano groups. | 03-12-2015 |
Qingquan Tang, Kingston, PA US
Patent application number | Description | Published |
---|---|---|
20150021983 | AIRCRAFT UNIVERSAL POWER CONVERTER - A power supply system suitable for use by an aircraft is disclosed. The power system converts power from an unregulated DC power source to multiple AC and DC voltage outputs. The power supply system comprises an interleaved buck converter, and interleaved full-bridge converter, an interleaved inverter, and a control system. In one configuration, the interleaved inverter uses high-voltage DC generated by the interleaved four-bridge converter as its power input to generate a high-voltage AC output. | 01-22-2015 |
20150021994 | POWER CONVERTER HAVING EMI FILTER COMMON TO MULTIPLE CONVERTERS - A power supply system is disclosed that includes a first interleaved power supply, a second interleaved power supply, and a common electromagnetic interference filter. The common electromagnetic interference filter is configured to provide DC power from a DC power source to both the first interleaved power supply and the second interleaved power supply. In one example, the common electromagnetic interference filter comprises a localized filter stage configured to receive DC power from the DC power source, and a distributed filter stage configured to receive DC power from the localized filter stage. The distributed filter stage includes a first set of common mode capacitors electrically connected to and physically proximate input power lines of the first interleaved power supply, and a second set of common mode capacitors electrically connected to and physically proximate input power lines of the second interleaved power supply. | 01-22-2015 |
20150214832 | Three-Phase Inverter with a Repositioned Choke - A method and apparatus for converting direct current into alternating current. The direct current is converted into a number of alternating currents using a switch system. The number of alternating currents is filtered using a set of inductors and a set of capacitors. Higher-frequency electromagnetic interference is blocked using a choke located between the set of inductors and the set of capacitors. | 07-30-2015 |
20150214854 | Conversion System for Converting Direct Current into Alternating Current - A method and apparatus for converting direct current into alternating current. An initial voltage level of an input voltage source is changed using a dual converter to form a plurality of voltage sources. Each of the plurality of voltage sources has voltage levels different from the initial voltage level. An inverter is supplied direct current from the plurality of voltage sources formed by the dual converter. The direct current is converted into a number of alternating currents using the inverter. | 07-30-2015 |
Robert H. Tang, Murrysville, PA US
Patent application number | Description | Published |
---|---|---|
20100134866 | OPTICAL ELEMENT HAVING AN APODIZED APERTURE - Provided is an optical element with an electrochromic apodized aperture having variable light transmittance in response to the amplitude of an applied voltage. The apodized aperture includes (i) a first substrate having a planar inner surface and an outer surface, (ii) a second substrate having an outer surface and a non-planar inner surface opposing and spaced from the planar inner surface of the first substrate, wherein each of the planar inner surface of the first substrate and the non-planar inner surface of the second substrate has an at least partial layer of transparent conductive material thereover; and (iii) an electrochromic medium disposed between the planar inner surface of the first substrate and the non-planar inner surface of the second substrate. | 06-03-2010 |
20130206323 | METHOD OF MAKING AN OPTICAL ELEMENT HAVING AN ELECTROCHROMIC APODIZED APERTURE - A method of forming an optical element which includes an electrochromic apodized aperture having variable light transmittance through a clear aperture area in response to an applied electrical current is disclosed. The apodized aperture includes a body including an area defining the clear aperture area wherein a fluid containment area substantially overlapping the clear aperture area, and includes at least one fill passage extending from the fluid containment area to at least one fill port outside of the clear aperture area; an electrochromic fluid within the fluid containment area substantially overlapping the clear aperture area and having variable light transmittance in response to an applied electrical current; a cover attached with the electrochromic fluid between the cover and body; electrical contacts electrically coupled to the electrochromic fluid for supplying electrical current thereto; and at least one passage seal in each said fill passage positioned outside of the clear aperture area. | 08-15-2013 |
20130215489 | OPTICAL ELEMENT HAVING AN ELECTROCHROMIC APODIZED APERTURE AND AN APERTURE BODY FORMING AN ELECTROCHROMIC APODIZED APERTURE - An optical element includes an electrochromic apodized aperture having variable light transmittance through a clear aperture area in response to an applied electrical current. The apodized aperture includes an aperture body including an area defining the clear aperture area, the body having a fluid containment area substantially overlapping the clear aperture area, and includes at least one fill passage extending from the fluid containment area to at least one fill port outside of the clear aperture area; an electrochromic fluid within the fluid containment area substantially overlapping the clear aperture area and having variable light transmittance in response to an applied electrical current; a cover attached with the electrochromic fluid between the cover and body; electrical contacts electrically coupled to the electrochromic fluid for supplying electrical current thereto; and at least one passage seal in each said fill passage positioned outside of the clear aperture area. | 08-22-2013 |
20130259464 | OPTICAL MECHANISM WITH INDEXING STAGE WITH AT LEAST ONE FIXED DIAMETER APODIZED APERTURE AND METHOD OF MAKING SAME - An optical mechanism for a camera having a camera aperture includes an indexing stage movable between at least two distinct positions. At least a first fixed diameter apodized aperture is mounted on the stage and configured to be aligned with the camera aperture in one of the distinct positions of the indexing stage, and wherein the first fixed diameter apodized aperture is not aligned with the camera aperture in the other of the distinct positions of the indexing stage. The stage can include multiple fixed diameter apodized apertures of distinct effective diameters each of which can be selectively aligned with the camera aperture. The mechanism includes an actuator for moving the stage between each of said distinct positions. Methods for mass producing the fixed diameter apodized aperture are disclosed using dye diffusion into optical elements via various methods, and various casting and molding formation techniques. | 10-03-2013 |
Shu-Guo Tang, Chalfont, PA US
Patent application number | Description | Published |
---|---|---|
20150059957 | SYSTEMS AND METHODS FOR MEASURING PHYSICAL CHARACTERISTICS OF SEMICONDUCTOR DEVICE ELEMENTS USING STRUCTURED LIGHT - A method of determining a physical characteristic of an adhesive material on a semiconductor device element using structured light is provided. The method includes the steps of: (1) applying a structured light pattern to an adhesive material on a semiconductor device element; (2) creating an image of the structured light pattern using a camera; and (3) analyzing the image of the structured light pattern to determine a physical characteristic of the adhesive material. Additional methods and systems for determining physical characteristics of semiconductor devices and elements using structured light are also provided. | 03-05-2015 |
Victoria Tang, Malvern, PA US
Patent application number | Description | Published |
---|---|---|
20140006423 | SYSTEMS AND METHODS FOR MATCHING MEDIA CONTENT DATA | 01-02-2014 |
Wing-Lung Tang, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20090129864 | CEMENTITIOUS PAVER - A cementitious paver comprising a first layer, a second layer, and a third layer. The first layer comprises a surface A, and a surface B opposite said surface A. The first layer comprises a first layer cementitious material that is substantially porous to water. The second layer comprises a surface C and a surface D opposite said surface C. Surface C is engaged with surface B. The second layer comprises a second layer cementitious material that is substantially non-porous to water. The second layer comprises a hole in fluid communication with surface C and in fluid communication with said surface D. The third layer comprises a surface E and a surface F opposite said surface E. Surface E is engaged with surface D. The third layer comprises a third layer cementitious material that is substantially porous to water. | 05-21-2009 |
Xiaoping Tang, North Wales, PA US
Patent application number | Description | Published |
---|---|---|
20090176278 | SOLVENTS FOR MUTANT ENDOGLYCOCERAMIDASES WITH SYNTHETIC ACTIVITY - The present invention provides reaction mixtures comprising a solvent having at least one of an alkoxy ether and/or a polyhydric alcohol for use in reactions with a mutant endoglycoceramidase having enhanced synthetic activity. | 07-09-2009 |
Xinjing Tang, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20080227742 | Photocleavable oligonucleotide and uses thereof - This invention relates to methods and compositions of oligonucleotide constructs having a photocleavable linker. Specifically, provided herein are methods and compositions utilizing a photocleavable linker, which when exposed to light modulates the expression of genes. | 09-18-2008 |
Xudong Tang, Lancaster, PA US
Patent application number | Description | Published |
---|---|---|
20150107800 | OPEN-LOOP THERMAL MANAGEMENT PROCESS AND SYSTEM - Open-loop thermal management systems and open-loop thermal management processes are disclosed. The process includes providing an open-loop thermal management system, saturating a reactor of the system with gas while a flow control unit prevents flow of the gas from the reactor, and maintaining a gas dissociation pressure range of the gas within the reactor. The system includes the reactor being arranged to receive a heat load. The reactor contains metal hydrides, metal organic framework, or a combination thereof. The reactor includes at least one venting line extending from the reactor. Also, the flow control unit is configured to adjustably control the flow of gas from the reactor to maintain the gas dissociation pressure range. | 04-23-2015 |
Xun Tang, Dresher, PA US
Patent application number | Description | Published |
---|---|---|
20090156078 | Polycarboxy emulsion copolymer binder compositions - The present invention provides flexible binder compositions comprising one or more polycarboxy emulsion copolymer has a measured Tg of 40° C. or less, such as from −45° C. to 25° C., and a polyol crosslinker. In one embodiment, the binder compositions comprising the polycarboxy emulsion copolymer can be used in making pultruded composites, such as sheets, for example, flexible gypsum board facing sheets, and flexible non-woven articles such as, for example, carpet backing. | 06-18-2009 |
20090156080 | Binder composition - A binder composition comprising an emulsion copolymer, and a polyol crosslinker. | 06-18-2009 |
20100069533 | Wood Adhesives Comprising Protein and Oxazoline Polymer or Resin - The present invention provides wood adhesive binder compositions comprising a naturally occurring protein component, e.g. soy flour, and an oxazoline-functional group containing polymer or resin component, the two components in a solids weight ratio of from 60:40 to 98:2. As formulated, the compositions may comprise from 40 to 98 wt. % of the naturally occurring protein component, preferably, 50 wt. % or more. Preferably, the wood adhesive binder further comprises lignins or lignosulfonate. Where the wood adhesive binder compositions comprise lignins or lignosulfonates, they remain more fluid and workable at a higher pH such as, for example, 4.5 or more. Any of the compositions may be formulated with one or more in situ acid generator compound to insure more rapid cure on heating or pressing. The binder enables the provision of mechanically sound, low cost and biodegradable composites, such as, medium density fiberboard (MDF). | 03-18-2010 |
20130251938 | POLYCARBOXY EMULSION COPOLYMER BINDER COMPOSITIONS - The present invention provides flexible binder compositions comprising one or more polycarboxy emulsion copolymer has a measured Tg of 40° C. or less, such as from −45° C. to 25° C., and a polyol crosslinker. In one embodiment, the binder compositions comprising the polycarboxy emulsion copolymer can be used in making pultruded composites, such as sheets, for example, flexible gypsum board facing sheets, and flexible non-woven articles such as, for example, carpet backing. | 09-26-2013 |
Yi Tang, Radnor, PA US
Patent application number | Description | Published |
---|---|---|
20110200627 | ANTI-CD147 ANTIBODIES, METHODS AND USES - The present invention provides antibodies immunospecific for human CD 147 capable of blocking bioactivity of CD 147 associated with malignant disease such as the stimulation of MMPs from fibroblast cells by tumor cells, the release of VEGF, and the promotion of angiogenesis. The antibodies of the present invention of are useful in treating malignant disease and those diseases in which CD 147 activity is plays a pathogenic role, such as diseases of the eye, lung, and cardiovascular system. | 08-18-2011 |
20140079711 | ANTI-CD147 ANTIBODIES, METHODS AND USES - The present invention provides antibodies immunospecific for human CD147 capable of blocking bioactivity of CD147 associated with malignant disease such as the stimulation of MMPs from fibroblast cells by tumor cells, the release of VEGF, and the promotion of angiogenesis. The antibodies of the present invention of are useful in treating malignant disease and those diseases in which CD147 activity is plays a pathogenic role, such as diseases of the eye, lung, and cardiovascular system. | 03-20-2014 |
Yi Tang, Drexel Hill, PA US
Patent application number | Description | Published |
---|---|---|
20090028862 | Emmprin antagonists and uses thereof - EMMPRIN (Extracellular Matrix Metalloproteinase Inducer) antagonists, such as antibodies, including specified portions or variants, siRNA, shRNA, antisense and DNAzymes, can be used to treat pathological processes associated with proliferative diseases, such as cancer, by specifically preventing or inhibiting the ability of proliferating tissue to develop a blood supply. | 01-29-2009 |
Yuan Tang, Elkins Park, PA US
Patent application number | Description | Published |
---|---|---|
20140186431 | COMBINED MESENCHYMAL STEM CELL TRANSPLANTATION AND TARGETED DELIVERY OF VEGF FOR TREATMENT OF MYOCARDIAL INFARCTION - Compositions and kits useful for the treatment of myocardial infarction comprise (i) P-selectin-targeted carriers (e.g., P-selectin-targeted liposomes, quantum dots or biodegradable nanoparticles) comprising VEGF and (ii) MSCs. | 07-03-2014 |